Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial (HALT-C)
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms HALT-C
- 01 Mar 2011 Tolerability results assessing the incidence of depression published in the Journal of Affective Disorders.
- 08 Jun 2010 Planned number of patients changed from 1050 to 1350 as reported by Roche record.
- 04 Dec 2008 Results published in the New England Journal of Medicine.